GSK plc
—- Market cap
- —
- Debt
- +$44.87B
- Cash
- −$3.40B
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $1.78T · View financials
Decision snapshot: GSK stock price vs TSLA: inconclusive — current versus $1.59K implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TSLA's multiple
Implied fair value · at GSK's multiple
Needs GSK P/E.
Live quote
As of 2025-12-31
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GSK FY 2025 (ended Dec 31, 2025) · TSLA FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / 0% debt · EV / Revenue 18.35x · EV / EBITDA 161.87x
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
GSK plc · implied price per share
Bear
$4.93
Base
$5.80
Bull
$6.67
Tesla, Inc. · implied price per share
Bear
$20.15
Base
$23.71
Bull
$27.26
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
—
0.10x
Net debt / EBITDA
Leverage against operating earnings
5.76x
-3.34x
Cash and equivalents
Liquid reserves on the balance sheet
$3.40B
$44.06B
Total debt
Interest-bearing obligations outstanding
$44.87B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
PFIZER INC
GSK vs PFE
ELI LILLY & Co
GSK vs LLY
BRISTOL MYERS SQUIBB CO
GSK vs BMY
JOHNSON & JOHNSON
GSK vs JNJ
AbbVie Inc.
GSK vs ABBV
AMGEN INC
GSK vs AMGN
Lucid Group, Inc.
GSK vs LCID
FORD MOTOR CO
GSK vs F
General Motors Co
GSK vs GM
Enphase Energy, Inc.
GSK vs ENPH
PLUG POWER INC
GSK vs PLUG
COPART INC
GSK vs CPRT
$8.15B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.